ENTER


Полный размерЗакрыть

Epidemiology of Infectious Uveitis

Details
Written by Super User
Category: #2 (10) 2019
Published: 25 December 2019
Hits: 1459


https://doi.org/10.30702/Ophthalmology.2019/10.104454

Vitovska O. P.1, Rozumiy N. M.2, Ziabchenko N. V.1, 2


1Department of Ophthalmology, Bogomolets National Medical University, Kyiv, Ukraine
2Olexandrivska Clinical Hospital, Kyiv, Ukraine

Abstract. Uveitis – is a common, dangerous loss of vision of inflammatory ocular disease, which include several heterogeneous clinical entities. The prevalence of different types of uveitis depends on many factors such as age, gender, race, geographical distribution, environmental impact, genetics and social habits. Epidemiological study of uveitis is necessary to understand the etiology and immunopathogenesis of this disease group. The incidence and prevalence of uveitis differ depending on the etiology (infectious, non-infectious), age, gender, anatomical location of the inflammatory process (anterior, middle, posterior uveitis, panuveitis), histopathology (granulomatous, non-granulomatous), type of inflammation (acute, chronic, recurrent). Prevalence varies by geographic location. Infectious etiology of uveitis is common (30–60%) in developing countries. Herpes and toxoplasmosis are the leading etiological factors of uveitis. Non-infectious etiology, as a rule, are more common in the developed countries.

Keywords: uveitis, chorioretinitis, epidemiology, etiology, infection, developing countries.


REFERENCES

  1. Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013; 23:705–17.
  2. de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011; 30:452–70.
  3. Munoz-Femändez S, Martin-Mola E. Uveitis. Best Pract Res Clin Rheumatol. 2006; 20: 487–505.
  4. Wakefeld D, Chang JH. Epidemiology of Uveitis. Int Ophthalmol Clin. 2005; 45:1–13.
  5. Chang JH, Wakefeld D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002; 10: 263–79.
  6. Vadot E, Barth E, Billet P. Epidemiology of uveitis: preliminary results of a prospective study in the Savoy. In: Saari KM, ed. Uveitis Update. Amsterdam: Elsevier Science; 1984. p. 13–7.
  7. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Arch Ophthalmol. 1962; 68:502–15.
  8. Збітнева СВ. Захворюваність населення України на хвороби ока та його придаткового апарату. Вісн. соц. гігієни та орган. охорони здоров’я України. 2010;3:14–8. Zbytneva SV. [Morbidity in Ukraine on eye disease and its adnexa]. Bulletin of Social Hygiene and Health Protection Organization of Ukraine. 2010;3:14–8. Ukrainian.
  9. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004; 111:491–500.
  10. Trusko B, Thome J, Jabs D, et al. Standardization of Uveitis Nomenclature (SUN) Project. The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013; 52:259–265, S1–S6.
  11. Palmares J, Coutinho MF, Castro-Correia J. Uveitis in northern Portugal. Curr Eye Res. 1990; 9: 31–4.
  12. Weiner A, Ben Ezra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol. 1991; 112:151–8.
  13. Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993; 17:71–6.
  14. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community Based Uveitis Study Group. Am J Ophthalmol. 1996; 121:35–46.
  15. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996; 114:593–9.
  16. Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003; 11:277–86.
  17. Llorenç V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93: 561–7.
  18. Ronday MJ, Stilma JS, Barbe RF, et al. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol. 1994;78:690–3.
  19. Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol. 1996;80:956–61.
  20. Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–5.
  21. Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297–310.
  22. Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943–8.
  23. Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007;21:33–9.
  24. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–83.
  25. Al-Mezaine HS, Kangave D, Abu El-Asrar AM. Patterns of uveitis in patients admitted to a university hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2010;18:424–31.
  26. Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013;131:1405–12.
  27. Al Dhahri H, Al Rubaie K, Hemachandran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. Epub 2014 Jul 24.
  28. Al-Shakarchi FI. Pattern of uveitis at a referral center in Iraq. Middle East Afr J Ophthalmol. 2014;21:291–5.
  29. Cunningham ET Jr. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251–61.
  30. Merle H, Cabre P, Olindo S, et al. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in Martinique (French West Indies). Am J Ophthalmol. 2002;134:190–5.
  31. Yeung IY, Popp NA, Chan CC. The role of sex in uveitis and ocular inflammation. Int Ophthalmol Clin. 2015;55:111–31.
  32. Ellis FD, Schlaegel TF Jr. The geographic localization of presumed histoplasmic choroiditis. Am J Ophthalmol. 1973;75:953–6.
  33. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136–44.
  34. Cooper PJ, Proano R, Beltran C, et al. Onchocerciasis in Ecuador: ocular findings in onchocerca volvulus infected individuals. Br J Ophthalmol. 1995;79:157–62.
  35. Nalcacioglu-Yuksekkaya P, Ozdal PC, Yazici A, et al. Clinical and demographic characteristics of patients with uveitis starting later in life. Ocul Immunol Inflamm. 2015;23:304–10.
  36. See RF, Rao NA. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am. 2002;15:529–36.
  37. Chang ML, Vitek C, Esparza J; WHO-UNAIDS-CDC. Public health considerations for the use of a first-generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20–21 November 2002. AIDS. 2003;17:W1–10.
  38. Schaftenaar E, van Gorp EC, Meenken C, et al. Ocular infections in sub-Saharan Africa in the context of high HIV prevalence. Trop Med Int Health. 2014;19:1003–14.
  39. Sauberan DP. Pediatric uveitis. Int Ophthalmol Clin. 2010;50:73–85.

Received: 19 May 2019

Published: December 2019